tyrosine has been researched along with pd 173074 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Darvann, T; Morriss-Kay, G; Ornitz, DM; Perlyn, CA; Tenenbaum, M | 1 |
Benitez, JA; Boyer, A; Cavenee, WK; Chen, CC; DeGroot, J; Fenton, TR; Furnari, FB; Gahman, TC; Galatro, T; Koga, T; Kolodner, RD; Li, J; Lindahl, E; Ma, J; Miki, S; Nagahashi Marie, SK; Orellana, L; Ponte de Albuquerque, C; Reed, R; Shiau, AK; Sulman, EP; Varki, NM; Zanca, C; Zhou, H | 1 |
2 other study(ies) available for tyrosine and pd 173074
Article | Year |
---|---|
A model for the pharmacological treatment of crouzon syndrome.
Topics: Animals; Cranial Sutures; Craniofacial Dysostosis; Cysteine; Disease Models, Animal; Mice; Mice, Mutant Strains; Mutation; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Tissue Culture Techniques; Tomography, X-Ray Computed; Tyrosine | 2006 |
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair.
Topics: Animals; Brain Neoplasms; Cell Nucleus; DNA Repair; Female; Glioma; Humans; Male; Mice; Phosphorylation; PTEN Phosphohydrolase; Pyrimidines; Rad51 Recombinase; Radiation Tolerance; Receptor, Fibroblast Growth Factor, Type 2; Tyrosine; Xenograft Model Antitumor Assays | 2019 |